Automated Immunoassay Multiplexing System (AIMS®)

AIMS® is a fully automated instrument that allows the processing of AtheNA Multi-Lyte® multiplexed assays and ZEUS Scientific ELISA II assays on the same platform.

By seamlessly incorporating the AtheNA Multi-Lyte® reader and an ELISA reader, AIMS® can fully automate both microtiter plate processes on the same platform for the first time.

Saving time and costs, AIMS® allows laboratories to maximize efficiency by offering complete walk-away performance for both AtheNA Multi-Lyte® and ZEUS Scientific ELISA II assays. The system also provides flexibility by al-lowing the user to select from several options including an instrument upgrade to current users of the AtheNA Multi-Lyte® who already have an instrument.

AIMS® is part of the AtheNA Multi-Lyte® product line which offers one of the broadest FDA cleared multiplexing menus in the clinical diagnostic arena. Combined with the extensive ZEUS Scientific ELISA product line, AIMS® pro-vides an efficient, open, fully automated solution in a multi-methodology format that can accommodate clinical testing labs of any size.

This short video introduces the Automated Immunoassay Multiplexing System (AIMS®), an open-configuration instrument permitting multiple automated assays to be performed in the same run. AIMS® is capable of processing ZEUS Scientific's AtheNA Multi-Lyte® and ELISA test kits.